The asthma–chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations

Samuel Louie Division of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine, University of California, Davis, CA 95616, USA; Division of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine, University of California, Davis, CA 95616, USA

Amir A Zeki Division of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine, University of California, Davis, CA 95616, USA; Division of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine, University of California, Davis, CA 95616, USA

Michael Schivo Division of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine, University of California, Davis, CA 95616, USA; Division of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine, University of California, Davis, CA 95616, USA

Andrew L Chan Division of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine, University of California, Davis, CA 95616, USA; Veterans Administration Northern California Health Care System, Martinez, CA 94553, USA; Division of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine, University of California, Davis, CA 95616, USA; Veterans Administration Northern California Health Care System, Martinez, CA 94553, USA

Ken Y Yoneda Division of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine, University of California, Davis, CA 95616, USA; Veterans Administration Northern California Health Care System, Martinez, CA 94553, USA; Division of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine, University of California, Davis, CA 95616, USA; Veterans Administration Northern California Health Care System, Martinez, CA 94553, USA

Mark Avdalovic Division of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine, University of California, Davis, CA 95616, USA; Veterans Administration Northern California Health Care System, Martinez, CA 94553, USA; Division of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine, University of California, Davis, CA 95616, USA; Veterans Administration Northern California Health Care System, Martinez, CA 94553, USA

Brian M Morrissey Division of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine, University of California, Davis, CA 95616, USA; Veterans Administration Northern California Health Care System, Martinez, CA 94553, USA; Division of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine, University of California, Davis, CA 95616, USA; Veterans Administration Northern California Health Care System, Martinez, CA 94553, USA

Timothy E Albertson Division of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine, University of California, Davis, CA 95616, USA; Veterans Administration Northern California Health Care System, Martinez, CA 94553, USA; Division of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine, University of California, Davis, CA 95616, USA. [email protected]; Veterans Administration Northern California Health Care System, Martinez, CA 94553, USA

show all

The asthma–chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The asthma–chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date